Skip to main content

Want a detailed portfolio tracker?

Aquestive Therapeutics (AQST) Market Cap (2018 - 2026)

Aquestive Therapeutics (AQST) market cap from Jul 25, 2018 to Jul 20, 2026. The current Aquestive Therapeutics (AQST) market cap is $490M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Aquestive Therapeutics (AQST) Market Cap CAGR table

PeriodCAGR
1 Year TTM+64.22%
3 Years TTM+102.04%
5 Years TTM+24.40%
All Time TTM+14.35%

Annual Market Cap change of Aquestive Therapeutics (AQST)

YearMarket CapChange
2026$490M-37.81%
2025$788M+142.26%
2024$325M+141.39%
2023$135M+177.51%
2022$49M-69.71%
2021$160M-13.28%
2020$185M-5.32%
2019$195M+24.23%
2018$157MN/A

Comparison Aquestive Therapeutics (AQST) market cap with competitors

Aquestive Therapeutics (AQST) market cap is $490.30M.

TickerNameMarket CapUpside
TAKTakeda Pharmaceutical Company$51.41B+10384.54%
HLNHaleon plc$43.67B+8806.31%
TEVATeva- Pharmaceutical Industries Ltd$36.48B+7340.99%
ZTSZoetis Inc - Class A$31.33B+6289.64%
UTHRUnited Therapeutics Corp$22.42B+4472.33%
VTRSViatris Inc$19.27B+3830.65%
NBIXNeurocrine Biosciences Inc$17.31B+3430.11%
ELANElanco Animal Health Inc$12.74B+2499.26%
RDYDr. Reddy`s Laboratories Ltd$10.66B+2074.26%
ALKSAlkermes plc$8.65B+1664.77%
HIMSHims & Hers Health Inc - Class A$8.48B+1629.79%
LQDALiquidia Corp$6.87B+1300.36%
LNTHLantheus Holdings Inc$6.79B+1284.56%
AMRXAmneal Pharmaceuticals Inc - Class A$5.44B+1008.62%
INDVIndivior Plc$5.08B+935.14%
KNSAKiniksa Pharmaceuticals International plc. - Class A$4.72B+862.73%
SUPNSupernus Pharmaceuticals Inc$2.77B+465.01%
RGCRegencell Bioscience Holdings Ltd$2.53B+416.88%
BCRXBiocryst Pharmaceuticals Inc$2.39B+387.51%
PBHPrestige Consumer Healthcare Inc$2.34B+377.94%
DCPHDeciphera Pharmaceuticals Inc$2.24B+356.10%
AVDLAvadel Pharmaceuticals plc$2.10B+329.16%
HCMHUTCHMED (China) Ltd$1.99B+305.77%
AMLXAmylyx Pharmaceuticals Inc$1.97B+302.62%
BHCBausch Health Companies Inc$1.83B+272.47%
DVAXDynavax Technologies Corp$1.82B+271.02%
ANIPANI Pharmaceuticals Inc$1.69B+244.74%
HROWHarrow Inc$1.60B+226.32%
XERSXeris Biopharma Holdings Inc$1.50B+206.19%
PRGOPerrigo Company plc$1.40B+185.89%
PAHCPhibro Animal Health Corp - Class A$1.37B+179.05%
COLLCollegium Pharmaceutical Inc$1.19B+142.70%
ALVOAlvotech$1.12B+127.69%
ETONEton Pharmaceuticals Inc$1.05B+114.84%
CRONCronos Group Inc$1.03B+110.27%
BIOABioAge Labs Inc$1.01B+105.50%
PCRXPacira BioSciences Inc$995.71M+103.08%
AMPHAmphastar Pharmaceuticals Inc$865.95M+76.62%
ESPREsperion Therapeutics Inc$799.30M+63.02%
EVOEvotec SE$713.80M+45.58%
IRWDIronwood Pharmaceuticals Inc - Class A$658.45M+34.30%
TLRYTilray Brands Inc$510.48M+4.11%
KMDAKamada Ltd$422.05M-13.92%
EBSEmergent Biosolutions Inc$408.18M-16.75%
CGCCanopy Growth Corporation$402.23M-17.96%
EOLSEvolus Inc$392.41M-19.97%
AKBAAkebia Therapeutics Inc$369.70M-24.60%
ORGOOrganogenesis Holdings Inc - Class A$320.40M-34.65%
SCYXScynexis Inc$299.71M-38.87%
TKNOAlpha Teknova Inc$283.60M-42.16%
SIGASIGA Technologies Inc$255.34M-47.92%
ANIKAnika Therapeutics Inc$212.78M-56.60%
DERMJourney Medical Corp$198.51M-59.51%
LFCRLifecore Biomedical Inc$182.14M-62.85%
ADCTAdc Therapeutics SA$162.77M-66.80%
ACBAurora Cannabis Inc$152.87M-68.82%
ASRTAssertio Holdings Inc$151.46M-69.11%
CRDLCardiol Therapeutics Inc - Class A$120.98M-75.33%
CPIXCumberland Pharmaceuticals Inc$116.87M-76.16%
OGIOrganiGram Holdings Inc$116.62M-76.21%
TLPHTalphera Inc$72.07M-85.30%
CTORCitius Oncology Inc$64.05M-86.94%
DRRXDurect Corp$59.52M-87.86%
INCRINC Research Holdings Inc$48.38M-90.13%
IXHLIncannex Healthcare Inc$44.20M-90.99%
ZYBTZhengye Biotechnology Holding Ltd$35.46M-92.77%
CPHIChina Pharma Holdings Inc$29.07M-94.07%
BTAIBioXcel Therapeutics Inc$24.95M-94.91%
AYTUAytu BioPharma Inc$23.83M-95.14%
TXMDTherapeuticsMD Inc$22.45M-95.42%
RMTIRockwell Medical Inc$22.26M-95.46%
EVOKEvoke Pharma Inc$18.95M-96.14%
BFRIBiofrontera Inc$12.94M-97.36%
CABRCaring Brands Inc$11.67M-97.62%
APUSApimeds Pharmaceuticals US Inc$8.51M-98.26%
BGMQilian International Holding Group Ltd - Class A$7.45M-98.48%
PRFXPRF Technologies Ltd$7.36M-98.50%
YCBDcbdMD Inc$6.72M-98.63%
INMInMed Pharmaceuticals Inc$6.44M-98.69%
GELSGelteq Ltd$5.56M-98.87%
RDHLRedhill Biopharma Ltd$5.20M-98.94%
SBFMSunshine Biopharma Inc$4.80M-99.02%
SNOASonoma Pharmaceuticals Inc$3.55M-99.28%
UPCUniverse Pharmaceuticals Inc$2.76M-99.44%
AKANAkanda Corp$2.23M-99.54%
SHPHShuttle Pharmaceuticals Holdings Inc$2.03M-99.59%
IMCCIM Cannabis Corp$1.58M-99.68%
SXTCChina SXT Pharmaceuticals Inc$1.00M-99.80%